The allosteric control of aspartate transcarbamoylase (ATCase, EC 2.1.3.2) of Escherichia coli involves feedback inhibition by both CTP and UTP rather than just CTP alone. It has been known that CTP functions as a heterotropic inhibitor of catalysis; however, the inhibition by CTP alone is incomplete (50-70% at various aspartate concentrations) and there is only a partial occupancy of the allosteric binding sites by CTP at saturating concentrations. The logic of these allosteric characteristics can now be understood in that UTP is a synergistic inhibitor of ATCase in the presence of CTP even though UTP has no independent effect at pH 7.0. When saturating concentrations of CTP are present, the concentration of substrate required for half-maximal activity (So.s) of the native holoenzyme for aspartate increases from 5 to 11 mM. When CTP and UTP are both present, the aspartate requirement increases further (S0.5 = 17 mM). At aspartate concentrations <5 mM, the heterotropic inhibition of ATCase is 90-95% in the presence of both pyrimidine nucleotides. UTP does enhance the binding of CTP to the holoenzyme but the number of tight binding sites does not change (n = 3). Biol. 196, have described a structural asymmetry across the molecular two-fold axis that is consistent with these CTP/UTP interactions. The synergistic inhibition of ATCase by both CTP and UTP provides a satisfying logic for ensuring a balance of endogenous pyrimidine nucleotide pools.The aspartate transcarbamoylase (ATCase, EC 2.1.3.2) of Escherichia coli provides a classic example of an enzyme subject to allosteric control by the end product of its biosynthetic pathway (1, 2). The holoenzyme of ATCase is composed of two separable catalytic trimers (c3) and three regulatory dimers (r2) that interact through a variety of specific protein-protein interfaces (3, 4). These interactions provide for specific conformational transitions (4-7) of the holoenzyme, 2(c3):3(r2), which result in changes in the catalytic rates and ligand affinities (8-10). Upon binding of substrates and/or substrate analogues the enzyme appears to make a concerted transition from an inactive "T conformation" (condensed form of the enzyme) to an expanded, more active "R conformation" (5-7). CTP affects catalysis by increasing the concentration of aspartate required to produce maximal activity. In contrast, ATP decreases the substrate requirement without altering the Vmax of the enzyme (1, 2).Both nucleotide effectors have been shown to competitively bind at the same allosteric sites even though they induce different heterotropic effects on catalysis (11)(12)(13)(14). Other pyrimidine nucleotides, specifically UTP and TTP, do not have any effect. GTP does promote a significant inhibitory effect under some conditions (25-30%) but less than that of CTP (50-70%). 8-Bromoguanosine 5'-triphosphate, as well as gadolinium complexes of ATP, CTP, and GTP, binds to the regulatory subunits, whereas UTP does not appear to bind to the native enzyme (11-13). These allosteric controls have bee...